4.31 USD
▼+0.19-2.49%
盘后 4.48 +1.36%
2026-08-03
市值
$709.48M
市盈率
6.98
EPS
0.62
股息率
—
52 周区间
0.72 – 5.78
成交量
5.77M
Beta
0.21
目标价
6.35
52W 低 0.7252W 高 5.78
价格走势
公司简介
Ironwood Pharmaceuticals, Inc., a biotechnology company, focuses on the development and commercialization of therapies for gastrointestinal (GI) and rare diseases in the United States and internationally. It sells linaclotide, a guanylate cyclase type-C (GC-C) agonist for the treatment of adults suffering from irritable bowel syndrome with constipation or chronic idiopathic constipation, as well as for pediatric patients suffering from functional constipation under the LINZESS and CONSTELLA names. The company is also developing IW-3300, a GC-C ...